Staying Relevant With Blockbuster Technology

February 16, 2021

Staying Relevant With Blockbuster Technology

Watch recording

Over the last decades the world has seen a range of commercially successful products. Especially in the pharma sector blockbuster drugs yield exceedingly high revenues. The main reason for the commercial success of these products is the fact that the underlying active ingredient was and still is protected by patents. Hence, the drug can be sold exclusively. After these patents reach their 20 year maximum lifetime, usually, cheaper generics enter the market drastically decreasing revenue for the original drug. To tackle the effects of such patent cliffs companies try to extend the patent protection of their blockbuster technology.

In this on-demand webinar, we used LexisNexis® PatentSight® to look at the most common strategies and how to spot them.

View the Staying Relevant With Blockbuster Technology slides

What you will learn in this webinar:

  • How to identify relevant patent cliffs
  • How to map patents to products
  • Common ways to extend the patent protection of a blockbuster technology
  • How to identify these extension strategies

Provide actionable insights to support strategic decision-making

Effectively communicate the value of your IP with powerful insights and visualizations, enabling you to turn your patent department into a strategic consulting unit.

Taking patent analytics out of the ‘black box’

With LexisNexis® Intellectual Property Solutions, you benefit from a highly transparent scientific approach to patent data analysis. Forget opaque algorithms and analytics ‘black boxes’, we can show you exactly how we reached at our insights. Patent analytics solution, PatentSight®, is built on the foundation of ground-breaking validated research, which is often cited in leading scientific publications.

Brought together in the patent value indicator, the Patent Asset Index™, this objective approach to assessing patent quality and benchmarking patent portfolios has become a de facto standard in measuring portfolio strength.

High-quality data: a prerequisite for reliable patent analysis

LexisNexis Intellectual Property Solutions validates and quality-assures patent data by assigning patents to their accurate commercial owners and verifying their legal validity and remaining lifetime.

Superior datasets allow you to unveil valuable patent insights and see clearly who wields commercial power over the inventions that underpin promising patents.

Patent analyses conducted with PatentSight have proven to be more reliable than analyses based on unprocessed patent data.

Was this post helpful?